Dr. Henrik Harling

2cureX

Henrik Harling is an experienced surgeon within colorectal cancer and is Chief Business Officer at
2cureX. Dr. Harling is one of the founders of the Danish Colorectal Cancer Group (DCCG) in
Denmark and served as Chairman from 1994 to 2010. The DCCG develops and implements
guidelines for colorectal cancer treatment and is involved in deciding on implementation of new
diagnostic technologies in Denmark.

dont miss

IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients

Overview presentation that will provide insight in the importance of Functional Profiling of solid tumors in order to match individual cancer patients with an effective treatment design. 2cureX manufactures the IndiTreat® test which is currently available for Colorectal cancer.

EVEN MORE SEMINARS

  • Islam Elkonaissi: Speaking at the Oncology Convention

    Islam Elkonaissi
    The Royal Marsden NHS Foundation Trust

    The Multi-Specialty Challenge of Cancer Care

  • Tim Windle: Speaking at the Oncology Convention

    Tim Windle
    Prostate Cancer UK

    Why research isn’t enough for patient access: the technology appraisal process

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Lucy Thompson ft. Stacie-rae Weir: Speaking at the Oncology Convention

    Lucy Thompson ft. Stacie-rae Weir
    Nipple Innovation Project

    Healing power of permanent realism in restorative tattooing

  • Louisa Davies: Speaking at the Oncology Convention

    Louisa Davies
    University College Hospital

    Is cancer crowdfunding fuelling quackery